D
Dmitry Bokov
Researcher at I.M. Sechenov First Moscow State Medical University
Publications - 128
Citations - 1317
Dmitry Bokov is an academic researcher from I.M. Sechenov First Moscow State Medical University. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 5, co-authored 51 publications receiving 80 citations.
Papers
More filters
Journal ArticleDOI
Liposomes: Structure, Biomedical Applications, and Stability Parameters With Emphasis on Cholesterol
Pooria Nakhaei,Ria Margiana,Dmitry Bokov,Walid Kamal Abdelbasset,Walid Kamal Abdelbasset,Mohammad Amin Jadidi Kouhbanani,Rajender S. Varma,Faroogh Marofi,Mostafa Jarahian,Nasrin Beheshtkhoo +9 more
TL;DR: The role of cholesterol in the stability of liposomes is discussed in this paper, where the authors focus on cholesterol as a promising material for liposome stability and provide an explanation for the stability promotion.
Journal ArticleDOI
Study on novel fluorescent carbon nanomaterials in food analysis
Ngafwan Ngafwan,Harun Rasyid,Emad Salaam Abood,Walid Kamal Abdelbasset,Sarmad Ghazi Al-Shawi,Dmitry Bokov,Abduladheem Turki Jalil +6 more
TL;DR: In this article, carbon quantum dots (CQDs) are used to detect food additives, heavy metals, bacteria, insecticide residues, antibiotics, and nutritional components in food samples.
Journal ArticleDOI
Anticancer Drug-Loading Capacity of Green Synthesized Porous Magnetic Iron Nanocarrier and Cytotoxic Effects Against Human Cancer Cell Line
Mohammad Javed Ansari,Saad Jasim,Talib Zeedan Taban,Dmitry Bokov,Mohammed Nader Shalaby,Moaed E. Al-Gazally,Hamzah H. Kzar,Maytham T. Qasim,Yasser Fakri Mustafa,Mehrdad Khatami +9 more
TL;DR: Porous hematite α-Fe2O3 nanoparticles (NPs) synthesized using plant extract induced morphological alterations compatible with the occurrence of apoptotic cell death and anticancer drug-loaded PMΑ NPs had better cytotoxic effects against melanoma cell line, evidenced via MTT and LDH leakage assays.
Journal ArticleDOI
Humoral immune mechanisms involved in protective and pathological immunity during COVID-19.
Gunawan Widjaja,Abduladheem Turki Jalil,Heshu Sulaiman Rahman,Walid Kamal Abdelbasset,Dmitry Bokov,Wanich Suksatan,Mahnaz Ghaebi,Faroogh Marofi,Jamshid Gholizadeh Navashenaq,Farhad Jadidi-Niaragh,Majid Ahmadi +10 more
TL;DR: In this paper, the authors describe the pathophysiology and clinical relevance of these distinct entities in the course of COVID-19 that resemble sepsis and further highlight two effector arms of the humoral immune response (inflammatory cytokine and immunoglobulin production) during COVID19 infection.
Journal ArticleDOI
Cancer combination therapies by angiogenesis inhibitors; a comprehensive review
Mohammad Javed Ansari,Dmitry Bokov,Alexander V. Markov,Abduladheem Turki Jalil,Mohammed Nader Shalaby,Wanich Suksatan,Supat Chupradit,Hasan S. Al-Ghamdi,Navid Shomali,A. Zamani,Ali Mohammadi,Mehdi Dadashpour +11 more
TL;DR: In this article , the authors focus on clinical developments of angiogenesis blockade therapy, more particular, in combination with other conventional treatments, such as immunotherapy, chemoradiotherapy, targeted therapy, and also cancer vaccines.